WPP forms largest healthcare coms network

June 25, 2010
Medical Communications CommonHealth, Ogilvy, WPP, ogilvy healthworld advertising

Global communications giant WPP has merged its Ogilvy Healthworld and CommonHealth businesses. Named Ogilvy CommonHealth Worldwide, the new entity becomes …

Merck moves tropical disease drug into phase II

June 25, 2010
Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease

Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …

Clavis Pharma appoints Athos Gianella-Borradori

June 24, 2010
Research and Development Clavis Pharma, appointment, research and development

Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …

NICE rejects Glivec as adjuvant therapy

June 24, 2010
Sales and Marketing Glivec, NICE, Novartis

NICE has rejected the use of Novartis’ Glivec as an adjuvant treatment for people who have had a gastrointestinal stromal …

AstraZeneca and Targacept begin depression trials

June 24, 2010
Research and Development AstraZeneca, Targacept, depression

AstraZeneca and Targacept have begun enrolling patients in phase III trials for TC-5214, a new treatment for depression. The new …

CME Spotlight: Coalition politics in European CME

June 24, 2010
Medical Communications CME, CME Spotlight

The election is now over and rather than the damp squib that I foresaw, it feels like something new and …

Prix Galien shortlist unveiled

June 24, 2010
Research and Development prix galien

The shortlist of innovative medicines which will compete for two prestigious UK Prix Galien medals later this year has been …

Pfizer plant cleared by FDA to make NicOx drug

June 24, 2010
Manufacturing and Production Capsugel, NicOx, Pfizer, manufacturing, naproxcinod

Pfizer subsidiary Capsugel has won approval from the US Food and Drug Administration for a manufacturing facility based in France …

Blog footer

Digital Pharma: Playing healthcare games

June 23, 2010
Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games

Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …

UKCRMI

Plans for UK’s research hub unveiled

June 23, 2010
Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome, biomedical

The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …

Prosensa and GSK add to muscular dystrophy alliance

June 23, 2010
Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy

GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …

George Osborne

Mixed reaction for Osborne’s first Budget

June 23, 2010
Research and Development, Sales and Marketing biotech, pharma, tax, tax relief

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …

Congress summons J&J chief executive

June 23, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …

PRA bolsters late phase services

June 23, 2010
Research and Development CRO, PRA, appointment, research and development

Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …

Sanofi signs microRNA therapy deal

June 23, 2010
Research and Development RNA, Regulus, Sanofi-Aventis

Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …

Medical Affairs at the Centre of Life Sciences Innovation

June 22, 2010
Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …

Europe must move on from ‘simplistic’ pricing

June 22, 2010
Research and Development Europe, hta, pricing, pricing & Reimbursement

GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …

Pfizer withdraws blood cancer drug in US

June 22, 2010
Sales and Marketing AML, Mylotarg, Pfizer, blood cancer

The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …

NHS targets and management costs in the firing line

June 22, 2010
NHS, NHS funding, NHS targets

Management costs and the use of targets are at the top of the government’s NHS hitlist, the health secretary Andrew Lansley has …

FDA tightens pharma’s responsibility for outsourcing

June 22, 2010
Manufacturing and Production FDA, GMP, manufacturing, outsourcing

Pharmaceutical manufacturers will be held more responsible for the activities of their suppliers and outsourcing partners under a new approach …

The Gateway to Local Adoption Series

Latest content